Oral anticoagulation for the antiphospholipid antibody syndrome: can we now say less is more?
نویسندگان
چکیده
منابع مشابه
Anticoagulation in the antiphospholipid syndrome.
Our objectives were to evaluate thrombotic complications in patients with lupus anticoagulant fulfilling Sapporo criteria, anticoagulated with an intended INR 2.0-3.0 due to venous and arterial thrombosis. In our series standard anticoagulation was safe and efficacious in preventing recurrences in patients with systemic lupus erythematosus, with other thrombophilia and with arterial thrombosis.
متن کاملNodding syndrome--we can now prevent it.
On Monday December 21, 2015, an information session was organized by the Ugandan Health minister Dr Elioda Tumwesigye in Pader district, northern Uganda, to explain the results of the investigations performed in Uganda to identify the cause of nodding syndrome (NS). NS was first reported in Uganda in the districts of Kitgum, Pader, and Lamwo in 2009. Retrospective studies would suggest cases as...
متن کاملControversies in the antiphospholipid syndrome: can we ever stop warfarin?
Patients with antiphospholipid syndrome are at increased risk for recurrent arterial and venous thrombosis and therefore benefit from long term warfarin therapy. The optimal duration of warfarin therapy after a first venous thromboembolic event is however a matter of some controversy and many questions remain unanswered. After reviewing and analysing the available evidence, we discuss some comm...
متن کاملCan we say what diet is best for health?
Diet is established among the most important influences on health in modern societies. Injudicious diet figures among the leading causes of premature death and chronic disease. Optimal eating is associated with increased life expectancy, dramatic reduction in lifetime risk of all chronic disease, and amelioration of gene expression. In this context, claims abound for the competitive merits of v...
متن کاملPSA testing in general practice: can we do more now?
The Medical Journal of Australia ISSN: 0025-729X 19 April 2004 180 8 379-381 ©The Medical Journal of Australia 2004 www.mja.com.au Conference Report THE DEBATE OVER PROSTATE-SPECIFIC ANTIGEN (PSA) testing for prostate cancer has been prolonged, public, and sometimes acrimonious. Despite this, a common theme is present in most evidence-based guidelines produced to date: while population-based sc...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Thrombosis and Haemostasis
سال: 2005
ISSN: 1538-7933,1538-7836
DOI: 10.1111/j.1538-7836.2005.01348.x